News

MMRV Combo Vaccine Is About as Safe as Separate MMR and Varicella Shots

Author and Disclosure Information

Key clinical point: If you’re okay with a slightly higher risk of febrile seizures, MMRV vaccine might be the way to go with your toddlers.

Major finding: There were 0.86 cases of meningitis/encephalitis per 100,000 doses of MMR+V and 1.86 cases per 100,000 doses of MMRV within 3 weeks of vaccination; similarly, there were 0.52 cases of arthritis/arthralgia per 100,000 doses for MMR+V and 0.84 cases for MMRV per 100,000 doses. The differences “could be ruled out with 95% confidence,” according to the investigators.

Data source: Diagnostic codes after 123,200 doses of the MMRV combination vaccine and 584,987 doses of MMR+V vaccines in children 12-23 months old.

Disclosures: Dr. Klein, Dr. Roger Baxter, and Allison Naleway, Ph.D., disclosed research funding from Merck, which manufactures the vaccines used in the study, and GlaxoSmithKline, among other industry ties. Dr. Edward A. Belongia reported research support from Medimmune. The remaining authors reported no relevant financial disclosures. The work was funded by the CDC.


 

FROM PEDIATRICS

References

MMR-varicella vaccine is about twice as likely to cause febrile seizures in toddlers than separate, same-day MMR and varicella shots, but it’s otherwise just as safe, according to a review of adverse events in children 12-23 months old vaccinated between 2000 and 2012.

The investigators – all from institutions participating in the Centers for Disease Control and Prevention’s Vaccine Safety Datalink project – compared outcomes after 123,200 doses of the MMR-varicella (MMRV) combination vaccine and 584,987 doses of MMR and varicella (MMR+V) vaccines given on the same day (Pediatrics 2015 [doi:10.1542/peds.2014-1822]).

There were no statistically significant difference in the main outcomes: anaphylaxis, immune thrombocytopenia purpura (ITP), ataxia, arthritis, meningitis/encephalitis, acute disseminated encephalomyelitis, and Kawasaki disease. “This study provides reassurance that most of these outcomes are extremely rare and unlikely after either vaccine,” said Dr. Nicola P. Klein of the Kaiser Permanente Vaccine Study Center in Oakland, Calif., and her associates.

For instance, they found 0.86 cases of meningitis/encephalitis per 100,000 doses of MMR+V, and 1.86 per 100,000 doses of MMRV within 3 weeks of vaccination. Similarly, there were 0.52 cases per 100,000 doses of arthritis/arthralgia for MMR+V, and 0.84 cases for MMRV. There were 2.93 Kawasaki cases per 100,000 doses of MMR+V, but no cases in the MMRV group. Such small differences “could be ruled out with 95% confidence,” the investigators said.

Two children had cases of anaphylaxis after MMRV shots, but neither “was confirmed as acute anaphylaxis after chart review; both diagnoses were related to a history of allergic reactions.” Even so, “continued monitoring for anaphylaxis after these vaccines is warranted,” they said. There were no cases of acute disseminated encephalomyelitis in either group.

Continue for additional adverse effects >>

Pages

Recommended Reading

Time to Change How We Test for TB?
Clinician Reviews
VIDEO: Study reignites dental antibiotic prophylaxis controversy
Clinician Reviews
VIDEO: Hepatitis C Screening Rises, But Where Are the Positive Cases?
Clinician Reviews
Sofosbuvir/GS-5816 Combo Offers Promising HCV Treatment Results
Clinician Reviews
CDC: Contact Lens Wearers Must Be Careful to Avoid Risk, Burden of Keratitis
Clinician Reviews
Experimental Ebola and Marburg Vaccines Safe, Well-Tolerated in Ugandan Adults
Clinician Reviews
Text Messages Prompt Parents to Vaccinate Their Kids
Clinician Reviews
Why Travel Health Belongs in Primary Care
Clinician Reviews
Woman, 32, With Crusty Red Blisters
Clinician Reviews
VIDEO: Herpes Zoster Vaccination: Is it Safe for Rheumatology Patients Over Age 30 on Biologics?
Clinician Reviews